Drug Type CAR-T |
Synonyms Claudin18.2-Targeted Chimeric Antigen Receptor T Cell |
Target |
Mechanism CLDN18.2 modulators(Claudin 18.2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastroesophageal junction adenocarcinoma | Phase 1 | CN | 17 Nov 2023 | |
stomach adenocarcinoma | Phase 1 | CN | 17 Nov 2023 |